Atlas Trials

Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma

Clinical trial NCT01108445 · COMPLETED

Trial details

NCT number
NCT01108445
Sponsor
Duke University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Non-clear Cell Renal Cell Carcinoma
Start date
2010-09-01
Primary completion
2015-02-01
Enrollment
131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.